PDI Evista Lessons Learned: Firm Focuses On Smaller Contracts, No Baselines
Executive Summary
PDI will focus on smaller contract sales opportunities in the 50-representative range following termination of the Evista promotion deal with Lilly, CEO Charles Saldarini said on a conference call Nov. 12
You may also be interested in...
Bristol Outsourcing Of Cefzil, Tequin To Ventiv May Be New Model For CSOs
Bristol Myers-Squibb's sales agreement with Ventiv for the promotion of the antibiotics Cefzil and Tequin may be a new model for using contract sales organizations in an environment of downsizing
Bristol Outsourcing Of Cefzil, Tequin To Ventiv May Be New Model For CSOs
Bristol Myers-Squibb's sales agreement with Ventiv for the promotion of the antibiotics Cefzil and Tequin may be a new model for using contract sales organizations in an environment of downsizing
PDI Combing Urology, Neurology Markets For Licensing/Acquisition Deals
PDI is aiming to build a "long-term portfolio" of specialty products through licensing deals, beginning in the urology and neurology markets